224 related articles for article (PubMed ID: 12637610)
1. Factors associated with progression of carcinoid heart disease.
Møller JE; Connolly HM; Rubin J; Seward JB; Modesto K; Pellikka PA
N Engl J Med; 2003 Mar; 348(11):1005-15. PubMed ID: 12637610
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease.
Denney WD; Kemp WE; Anthony LB; Oates JA; Byrd BF
J Am Coll Cardiol; 1998 Oct; 32(4):1017-22. PubMed ID: 9768727
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic follow-up of treated patients with carcinoid syndrome.
Mansencal N; Mitry E; Bachet JB; Rougier P; Dubourg O
Am J Cardiol; 2010 Jun; 105(11):1588-91. PubMed ID: 20494667
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the development and progression of carcinoid heart disease.
Bhattacharyya S; Toumpanakis C; Chilkunda D; Caplin ME; Davar J
Am J Cardiol; 2011 Apr; 107(8):1221-6. PubMed ID: 21296329
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease.
Mansencal N; McKenna WJ; Mitry E; Beauchet A; Pellerin D; Rougier P; Dubourg O
Am J Cardiol; 2010 Feb; 105(4):527-31. PubMed ID: 20152249
[TBL] [Abstract][Full Text] [Related]
6. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
Pellikka PA; Tajik AJ; Khandheria BK; Seward JB; Callahan JA; Pitot HC; Kvols LK
Circulation; 1993 Apr; 87(4):1188-96. PubMed ID: 7681733
[TBL] [Abstract][Full Text] [Related]
7. Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome.
Westberg G; Wängberg B; Ahlman H; Bergh CH; Beckman-Suurküla M; Caidahl K
Br J Surg; 2001 Jun; 88(6):865-72. PubMed ID: 11412260
[TBL] [Abstract][Full Text] [Related]
8. Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease.
Himelman RB; Schiller NB
Am J Cardiol; 1989 Feb; 63(5):347-52. PubMed ID: 2464278
[TBL] [Abstract][Full Text] [Related]
9. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.
Lundin L; Norheim I; Landelius J; Oberg K; Theodorsson-Norheim E
Circulation; 1988 Feb; 77(2):264-9. PubMed ID: 2448062
[TBL] [Abstract][Full Text] [Related]
10. Assessment of patent foramen ovale in carcinoid heart disease.
Mansencal N; Mitry E; Forissier JF; Martin F; Redheuil A; Lepère C; Farcot JC; Joseph T; Lacombe P; Rougier P; Dubourg O
Am Heart J; 2006 May; 151(5):1129.e1-6. PubMed ID: 16644350
[TBL] [Abstract][Full Text] [Related]
11. Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review.
Buchanan-Hughes A; Pashley A; Feuilly M; Marteau F; Pritchard DM; Singh S
Neuroendocrinology; 2021; 111(1-2):1-15. PubMed ID: 32097914
[TBL] [Abstract][Full Text] [Related]
12. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI
Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor.
Zuetenhorst JM; Bonfrer JM; Korse CM; Bakker R; van Tinteren H; Taal BG
Cancer; 2003 Apr; 97(7):1609-15. PubMed ID: 12655516
[TBL] [Abstract][Full Text] [Related]
14. Do indole markers predict carcinoid heart disease?
Arora RR; Warner RR
Chest; 1986 Jul; 90(1):87-9. PubMed ID: 2424676
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic diagnosis in carcinoid heart disease.
Wonnink-De JW; Knibbeler-Van RC; Van der Heul C; Pasteuning WH
Neth J Med; 2002 May; 60(4):181-5. PubMed ID: 12164398
[TBL] [Abstract][Full Text] [Related]
16. Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.
Dobson R; Burgess MI; Valle JW; Pritchard DM; Vora J; Wong C; Chadwick C; Keevi B; Adaway J; Hofmann U; Poston GJ; Cuthbertson DJ
Br J Cancer; 2014 Oct; 111(9):1703-9. PubMed ID: 25211656
[TBL] [Abstract][Full Text] [Related]
17. Role of hepatic resection for patients with carcinoid heart disease.
Bernheim AM; Connolly HM; Rubin J; Møller JE; Scott CG; Nagorney DM; Pellikka PA
Mayo Clin Proc; 2008 Feb; 83(2):143-50. PubMed ID: 18241623
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular abnormalities in patients with a carcinoid syndrome.
Meijer WC; van Veldhuisen DJ; Kema IP; Van den Berg MP; Boomsma F; Willemse PH; De Vries EG
Neth J Med; 2002 Mar; 60(1):10-6. PubMed ID: 12074037
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoid heart disease and primary ovarian tumor].
Targa L; Conti G; Gabellini A; Bergamo S; Rossetto A; Corbara F
Ital Heart J Suppl; 2002 Apr; 3(4):450-3. PubMed ID: 12025391
[TBL] [Abstract][Full Text] [Related]
20. Incidence and evolution of carcinoid syndrome in the heart.
Moyssakis IE; Rallidis LS; Guida GF; Nihoyannopoulos PI
J Heart Valve Dis; 1997 Nov; 6(6):625-30. PubMed ID: 9427132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
